CN Patent

CN108137599B — 化合物

Assigned to University of Dundee · Expires 2020-10-27 · 6y expired

What this patent protects

式(I)的化合物或其盐，包含该化合物的组合物，其制备方法和其治疗用途，例如治疗寄生虫病如查加斯病、人非洲锥虫病(HAT)、动物非洲锥虫病(AAT)和利什曼病，特别是内脏利什曼病(VL)。

USPTO Abstract

式(I)的化合物或其盐，包含该化合物的组合物，其制备方法和其治疗用途，例如治疗寄生虫病如查加斯病、人非洲锥虫病(HAT)、动物非洲锥虫病(AAT)和利什曼病，特别是内脏利什曼病(VL)。

Drugs covered by this patent

Patent Metadata

Patent number
CN108137599B
Jurisdiction
CN
Classification
—
Expires
2020-10-27
Drug substance claim
No
Drug product claim
No
Assignee
University of Dundee
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.